Abstract:Plasma rich in growth factors (PRGF) can be used over patients suffering from dermatoses due to its anti-inflammatory effect. However, this population group might present soluble autoimmune components and there is limited information about the effect of chronic skin inflammation on PRGF bioactive properties. With the aim of characterizing PRGF composition, PRGF from healthy (H) donors and patients with atopic dermatitis (AD), psoriasis (PS), or lichen sclerosus (LS) was obtained. In order to reduce the inflammatory component, leukocyte exclusion and heat-inactivation (Immunosafe) were tested. Haematological-serological parameters, platelet functionality, clot microstructure, protein content and bioactivity were determined. Mean values and 95% confidence intervals (mean[95% CI]) were computed for key haematological parameters, such as platelet (410×10 3 /mm 3 [371-449]) and leukocyte content (205×10 3 /mm 3 [148-262]), platelet activation (resting: 4.3%[3.1-5.5] and activated: 97.4%[96.7-98.0]), the concentration of plasma proteins and morphogens, including immunoglobulins A (210.7 mg/dL[191.8-229.6]), G (933.1 mg/dL[887.2-978.9]), E (783.5 mg/dL[54.4-1512.6]), and M (115.0 mg/dL[97.1-133.0]), Complement Protein (31.6 mg/mL[26.6-36.6]), C-Reactive protein (3.1 mg/L[2.0-4.1]), TGF-β1 (35975.6 pg/mL[34221.3-37729.8]), fibronectin (146410.0 ng/mL[136518.3-156301.7]), PDGF-AB (13308.5 pg/mL[12401.0-14216.0]), CD40L (2389.3 pg/mL[1887.7-2890.8]), IL-4 (0.12 pg/mL[0.07-0.18]), IL-13 (35.4 pg/mL[21.0-49.7]), IL-1β (0.09 pg/mL[0.06-0.11]) and TNF-α (0.31 pg/mL[0.24-0.38]), and also for cell proliferation (332.9ngDNA/mL[317.4-348.3]), viability (135.6%[132.0-139.2]) and migration (103.8cells/mm 2 [98.3-109.3]). Plasma from AD donors presented increased Immunoglobulin E (IgE) that was significantly reduced after Immunosafe along with the complement system and autoantibodies. Platelet functionality was altered for AD, but no microstructure differences were identified. Pathological groups presented reduced concentration of fibronectin (AD/LS) and Platelet-Derived Growth Factor (PDGF-AB) (P). Immunosafe treatment reduced Cluster of Differentiation 40 Protein (CD40L), interleukin 1β (IL-1β), and Tumor Necrosis Factor α (TNF-α) concentrations. Fibroblasts supplemented with PRGF obtained from pathological patients (PS/AD) showed reduced viability but Immunosafe increased cell proliferation and migration in SP (LS) and L-SP samples (PS/AD). In conclusion, PRGF derived from pathological patients present autoimmune components, but heat-inactivation or leukocyte exclusion could minimize local side effects.

Benefits of plasma rich in growth factors (PRGF) in skin photodamage: Clinical response and histological assessment

Experimental Study on the Mechanism of Nonablative Skin Photorejuvenation

Effect of Use of Platelet-Rich Plasma (PRP) in Skin with Intrinsic Aging Process

Effects of Autologous Platelet-Rich Plasma Injections on Facial Skin Rejuvenation.

The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study

Autologous pure platelet-rich plasma injections for facial skin rejuvenation: Biometric instrumental evaluations and patient-reported outcomes to support antiaging effects

Impact of inflammatory skin conditions on the biological profile of plasma rich in growth factor

Effects of plasma rich in growth factors on wound healing in patients with venous ulcers

Use of platelet rich plasma for skin rejuvenation

Clinical Evidence of Dermal and Epidermal Restructuring from a Biologically Active Growth Factor Serum for Skin Rejuvenation

Comparison Between Injectable Platelet‐rich Fibrin and Platelet‐rich Plasma in Ameliorating UVA‐induced Photoaging in Human Dermal Fibroblasts via the Activation of TGF‐β/Smad Signaling Pathway

PRGF Membrane with Tailored Optical Properties Preserves the Cytoprotective Effect of Plasma Rich in Growth Factors: In Vitro Model of Retinal Pigment Epithelial Cells

A systematic review of the safety and effectiveness of platelet-rich plasma (PRP) for skin aging

Fluid platelet‐rich fibrin stimulates greater dermal skin fibroblast cell migration, proliferation, and collagen synthesis when compared to platelet‐rich plasma

Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus

The therapeutic effect of sufficient oxygen-rich PRP injection in facial rejuvenation by multiple objective evaluations in 26 cases

Autologous platelet-rich gel for facial rejuvenation and wrinkle amelioration: A pilot study

Photoaging Skin Therapy with PRP and ADSC: A Comparative Study

A Personalized Nutrition Plan Improves Outcomes of Facial Regeneration With Platelet-rich Fibrin Liquid Matrixes

The effect of plasma rich in growth factors combined with follicular unit extraction surgery for the treatment of hair loss: A pilot study

Effect of Health Status and Heat-Induced Inactivation on the Proteomic Profile of Plasma Rich in Growth Factors Obtained from Donors with Chronic Inflammatory Skin Conditions